KNRUHS Notifies On Free Exit Of Candidates Admitted Into MDS Courses 2021-22
- byDoctor News Daily Team
- 14 July, 2025
- 0 Comments
- 0 Mins
Warangal: The Kaloji Narayana Rao University of Health Sciences (KNRUHS) has issued a notice for all the Candidates admitted under Management Quota for the academic year 2021-22 into Post Graduate MDS Courses and who desire to discontinue the course.
As per the notice, the concerned candidates have a choice of free exit to discontinue from the course in to which they are admitted before 2 Pm on 09-11-2021 without any penalty. However, candidates are informed that they will not be eligible for the Mop-up round of Management Quota if any, once they discontinue the course.
Candidates are informed that if they discontinue the course after 2.00 PM on 09-11-2021 onwards penalty clause will be applicable with payment of Rs.5,00,000/- ( Rupees Five Lakhs Only ) of Bond amount and debarred from admission into KNRUHS for 3-years.
All the Principals of Dental Colleges are hereby informed that they can relieve any candidate who wants to discontinue from the course from Management Quota admission for 2021-22 on written application from the candidate up to 2.00 PM on 09-11-2021.
The University has also released the college wise allotment list after the MOP UP phase of counselling, however, after the counselling some seats are left vacant. All the concerned candidates can view the lists as mentioned below:
College wise allotment list: https://.in/pdf_upload/mds-cq-mop-up-phase-college-wise-allotments-2021-22-163486.pdf
List of non joined candidates: https://.in/pdf_upload/not-joined-afterp2-mds-163487.pdf
Available vacancies: https://.in/pdf_upload/mds-cq-mop-up-vacancies-counselling-163488.pdf
To view the official notice click on the following link:
https://.in/pdf_upload/pg-mq-free-exit-notification-2021-22-163489.pdf
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Eli Lilly plans to build new USD 3 billion facilit...
- 04 November, 2025
Rajkot Maternity Hospital CCTV Leak: How a simple...
- 04 November, 2025
Gland Pharma profit rises 12 percent to Rs 184 cro...
- 04 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!